Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-023470

Director sold 4,000 shares at an average $73.68 ($294,736)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Connaughton Bernadette Director 2025-09-02 Sale 10b5-1 −100 $71.71 $7,171 50,852 D: show line 1 in the form
Connaughton Bernadette Director 2025-09-02 Sale 10b5-1 −2,977 $73.62 $219,161 47,875 D: show line 2 in the form
Connaughton Bernadette Director 2025-09-02 Sale 10b5-1 −923 $74.11 $68,404 46,952 D: show line 3 in the form
Open-market sales · 4,000 sh · avg $73.68 · $294,736
Loading xslF345X05/form4-09032025_120938.xml…